Shao Mu Guo
Direktor/Vorstandsmitglied bei YIDA CHINA HOLDINGS LIMITED
Aktive Positionen von Shao Mu Guo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
YIDA CHINA HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 01.06.2014 | - |
Independent Dir/Board Member | 01.06.2014 | - | |
GALAXYCORE INC. | Direktor/Vorstandsmitglied | 23.01.2014 | - |
Independent Dir/Board Member | 23.01.2014 | - | |
FANTASIA HOLDINGS GROUP CO., LIMITED | Direktor/Vorstandsmitglied | 01.02.2015 | - |
Independent Dir/Board Member | 01.02.2015 | - | |
SUNKWAN PROPERTIES GROUP LIMITED | Direktor/Vorstandsmitglied | 27.10.2020 | - |
Independent Dir/Board Member | 27.10.2020 | - | |
SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Direktor/Vorstandsmitglied | 23.11.2020 | - |
Independent Dir/Board Member | 23.11.2020 | - | |
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
Independent Dir/Board Member | 01.01.2018 | - | |
Shanghai Xinwei Medical Technology Co., Ltd.
Shanghai Xinwei Medical Technology Co., Ltd. BiotechnologyHealth Technology Shanghai Xinwei Medical Technology Co., Ltd. develops products for the prevention and treatment of stroke. The company is based in Shanghai, China. The Chinese company was founded in 2016 by Guo Hui Wang, who has been the CEO since 2016. | Direktor/Vorstandsmitglied | - | - |
Independent Dir/Board Member | - | - |
Karriereverlauf von Shao Mu Guo
Ehemalige bekannte Positionen von Shao Mu Guo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GANGLONG CHINA PROPERTY GROUP LIMITED | Direktor/Vorstandsmitglied | 01.06.2020 | 01.12.2023 |
Independent Dir/Board Member | 01.06.2020 | 01.12.2023 | |
Morgan Stanley Asia Ltd.
Morgan Stanley Asia Ltd. Investment Banks/BrokersFinance Morgan Stanley Asia Ltd. (MSA) is a broker/dealer headquartered in Hong Kong. The firm was founded in 1987 and is a subsidiary of Morgan Stanley (NYSE: MS) in the US. MSA provides institutional securities such as equities, fixed income, derivatives and research. | Corporate Officer/Principal | 01.04.2007 | 01.04.2013 |
░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Shao Mu Guo
Zhejiang University | Undergraduate Degree |
University of Southern California | Graduate Degree |
Yale School of Management | Masters Business Admin |
Statistik
International
China | 11 |
Hong Kong | 7 |
Vereinigte Staaten | 4 |
Operativ
Director/Board Member | 10 |
Independent Dir/Board Member | 8 |
Corporate Officer/Principal | 6 |
Sektoral
Finance | 8 |
Consumer Services | 4 |
Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 6 |
---|---|
YIDA CHINA HOLDINGS LIMITED | Finance |
GALAXYCORE INC. | Electronic Technology |
FANTASIA HOLDINGS GROUP CO., LIMITED | Finance |
GANGLONG CHINA PROPERTY GROUP LIMITED | Finance |
SUNKWAN PROPERTIES GROUP LIMITED | Finance |
SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Health Technology |
Private Unternehmen | 10 |
---|---|
Citigroup Global Markets China Ltd. | |
Salomon Smith Barney, Inc. | Finance |
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Health Technology |
HSBC Markets Asia Ltd. | |
Morgan Stanley Asia Ltd.
Morgan Stanley Asia Ltd. Investment Banks/BrokersFinance Morgan Stanley Asia Ltd. (MSA) is a broker/dealer headquartered in Hong Kong. The firm was founded in 1987 and is a subsidiary of Morgan Stanley (NYSE: MS) in the US. MSA provides institutional securities such as equities, fixed income, derivatives and research. | Finance |
Ljmjl Advisors Hk Ltd. | |
Mjl Fun Ltd. | |
HSBC Investment Asia Holdings Ltd. | |
JPMorgan Chase Bank (China) Co. Ltd.
JPMorgan Chase Bank (China) Co. Ltd. Regional BanksFinance Part of JPMorgan Chase & Co., JPMorgan Chase Bank (China) Co. Ltd. is a Chinese company that offers trade finance, cash management, and commercial banking. The company is based in Beijing, China. | Finance |
Shanghai Xinwei Medical Technology Co., Ltd.
Shanghai Xinwei Medical Technology Co., Ltd. BiotechnologyHealth Technology Shanghai Xinwei Medical Technology Co., Ltd. develops products for the prevention and treatment of stroke. The company is based in Shanghai, China. The Chinese company was founded in 2016 by Guo Hui Wang, who has been the CEO since 2016. | Health Technology |
- Börse
- Insiders
- Shao Mu Guo
- Erfahrung